HealthEquity (NASDAQ:HQY) EVP Sells $156,840.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. This represents a 1.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Delano Ladd also recently made the following trade(s):

• On Monday, October 20th, Delano Ladd sold 1,500 shares of HealthEquity stock. The shares were sold at an average price of $92.07, for a total value of $138,105.00.
• On Friday, September 19th, Delano Ladd sold 6,000 shares of HealthEquity stock. The stock was sold at an average price of $94.11, for a total value of $564,660.00.

HealthEquity Stock Performance

Shares of NASDAQ:HQY traded up $1.73 on Monday, hitting $103.64. The company had a trading volume of 736,975 shares, compared to its average volume of 999,475. The stock has a 50 day moving average price of $94.96 and a 200 day moving average price of $96.48. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The stock has a market cap of $8.93 billion, a price-to-earnings ratio of 62.81, a P/E/G ratio of 1.36 and a beta of 0.47. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $325.80 million for the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC grew its holdings in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity during the 2nd quarter valued at $33,000. WPG Advisers LLC bought a new position in shares of HealthEquity in the 1st quarter worth approximately $28,000. True Wealth Design LLC boosted its stake in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after acquiring an additional 317 shares during the last quarter. Finally, Cullen Frost Bankers Inc. grew its holdings in HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after purchasing an additional 224 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on HQY. JPMorgan Chase & Co. raised their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, September 3rd. BMO Capital Markets initiated coverage on HealthEquity in a research report on Thursday, November 13th. They issued a “market perform” rating and a $100.00 target price for the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Finally, Jefferies Financial Group lifted their target price on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $119.00.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.